Close Price | Market Cap | P/E Ratio | Forward P/E Ratio | Implied Growth* | Implied Forward Growth* | Dividend | P/B Ratio |
---|---|---|---|---|---|---|---|
$314.50 | $284.84B | 13.6 | 10.5 | 7.2% | 4.6% | $8.84 285.0% | 3.0 |
Date | Revenue | Net Income | EPS | Revenue Change | Net Income Change | EPS Change | |
---|---|---|---|---|---|---|---|
0 | 2021-12-31 | $287.6B | $17.3B | $18.33 | N/A | N/A | N/A |
1 | 2022-12-31 | $324.2B | $20.1B | $21.54 | 12.7% | 16.4% | 17.5% |
2 | 2023-12-31 | $371.6B | $22.4B | $24.22 | 14.6% | 11.2% | 12.4% |
3 | 2024-12-31 | $400.3B | $14.4B | $15.74 | 7.7% | -35.6% | -35.0% |
4 | TTM 2025-03-31 | $410.1B | $22.1B | $25.43 | 2.4% | 53.5% | 61.5% |
5 | Average | 9.3% | 11.4% | 14.1% |
2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Average | |
---|---|---|---|---|---|---|---|
Revenue Growth (%) | 12.7% | 14.6% | 7.7% | 12.1% | 3.8% | 10.2% | |
Revenue Analysts (#) | 0 | 0 | 0 | 0 | 9 | 9 | |
EPS Growth (%) | 16.4% | 11.2% | -35.6% | 1.9% | 8.0% | 0.4% | |
EPS Analysts (#) | 0 | 0 | 0 | 0 | 11 | 11 |
Year | Revenue ($) | Cost of Revenue ($) | Facilities / D&A ($) |
---|---|---|---|
2021 | $287.6B | $214.8B | $3.1B |
2022 | $324.2B | $241.1B | $3.4B |
2023 | $371.6B | $276.7B | $4.0B |
2024 | $400.3B | $306.8B | $4.1B |
TTM | $422.8B | $330.5B | $4.2B |
Year | Revenue Change (%) | Cost of Revenue Change (%) | Facilities / D&A Change (%) |
---|---|---|---|
2022 | 12.71 | 12.24 | 9.57 |
2023 | 14.64 | 14.74 | 16.82 |
2024 | 7.71 | 10.87 | 3.20 |
TTM | 5.63 | 7.72 | 3.12 |
Segment | 2022 Rev ($B) | 2022 OI ($B) | 2023 Rev ($B) | 2023 OI ($B) | 2024 Rev ($B) | 2024 OI ($B) | TTM Rev ($B) | TTM OI ($B) | % of Total (TTM) |
---|---|---|---|---|---|---|---|---|---|
Product | 150B | 0.00B | 170B | 0.00B | 201B | 0.00B | 216B | 0.00B | 61.3% |
Service | 100B | 0.00B | 126B | 0.00B | 134B | 0.00B | 137B | 0.00B | 38.7% |
Segment | 2022 Rev ($B) | 2022 OI ($B) | 2023 Rev ($B) | 2023 OI ($B) | 2024 Rev ($B) | 2024 OI ($B) | TTM Rev ($B) | TTM OI ($B) |
---|---|---|---|---|---|---|---|---|
Optum Health | – | – | – | – | – | – | 0.00B | -2.85B |
Optum Insight | – | – | – | – | – | – | 0.00B | 1.38B |
Optum Rx | – | – | – | – | – | – | 0.00B | 0.24B |
Optumhealth | 0.00B | 6.03B | 0.00B | 6.56B | 0.00B | 7.77B | 0.00B | 7.77B |
Optuminsight | 0.00B | 3.59B | 0.00B | 4.27B | 0.00B | 3.10B | 0.00B | 3.10B |
Optumrx | 0.00B | 4.44B | 0.00B | 5.12B | 0.00B | 5.84B | 0.00B | 5.84B |
Total Optum | 0.00B | 14.1B | 0.00B | 15.9B | 0.00B | 16.7B | 0.00B | 15.5B |
Unitedhealthcare | 0.00B | 14.4B | 0.00B | 16.4B | 0.00B | 15.6B | 0.00B | 12.6B |
Metric | Value | |
---|---|---|
0 | Total Assets | $309,790M |
1 | Cash | $30,717M |
2 | Total Liabilities | $204,621M |
3 | Total Debt | $81,271M |
4 | Total Equity | $95,038M |
5 | Debt to Equity Ratio | 0.86 |
Share Price | Treasury Yield | Estimates | Fair Value (P/E) | Fair Value (P/S) | Current P/S | Current P/E |
---|---|---|---|---|---|---|
$302.01 | 4.4% | Nicks Growth: 8% Nick's Expected Margin: 6% FINVIZ Growth: 2% |
Nicks: 14 Finviz: 8 |
Nick's: 0.857 | 0.7 | 12.6 |
Basis | Year | Nicks Valuation | Nicks vs Share Price | Finviz Valuation | Finviz vs Share Price |
---|---|---|---|---|---|
$25.43 EPS | TTM | $363.07 | 20.2% | $204.31 | -32.3% |
$22.28 EPS | 2025 | $318.10 | 5.3% | $179.00 | -40.7% |
$25.58 EPS | 2026 | $365.21 | 20.9% | $205.51 | -32.0% |
Average | Median | Std Dev | Current | Percentile | ||||||
---|---|---|---|---|---|---|---|---|---|---|
TTM | Forward | TTM | Forward | TTM | Forward | TTM | Forward | TTM | Forward | |
Timeframe | ||||||||||
1 Year | 6.34% | 3.91% | 6.72% | 4.37% | 0.85% | 0.89% | 7.09% | 4.55% | 82.8% | 70.7% |
3 Years | 6.34% | 3.91% | 6.72% | 4.37% | 0.85% | 0.89% | 7.09% | 4.55% | 82.8% | 70.7% |
5 Years | 6.34% | 3.91% | 6.72% | 4.37% | 0.85% | 0.89% | 7.09% | 4.55% | 82.8% | 70.7% |
10 Years | 6.34% | 3.91% | 6.72% | 4.37% | 0.85% | 0.89% | 7.09% | 4.55% | 82.8% | 70.7% |